See all treatments in the PatientsLikeMe system shared by patients just like you.
Brand Names:
Rilutek
Generic Name: Riluzole
What is Riluzole? Riluzole is the first drug to be approved for ALS. Riluzole, available as RilutekĀ®, does not cure ALS or improve symptoms, but may extend the survival of patients by approximately three months. It appears to be more effective in patients with bulbar-onset than for those with limb-onset.
See more information, including instructions, precautions, side effects, and interactions.
902 patients in the community are taking or have taken Riluzole.
| Reason | # Patients | Percentage of patients |
|---|---|---|
| Slow my ALS progress | 773 | 85% |
| disease-related symptoms | 17 | 1% |
| Other | 16 | 1% |
| Don't know | 8 | <1% |
| Stiffness/spasticity | 6 | <1% |
| General health | 6 | <1% |
| Fasciculations | 4 | <1% |
| Fatigue | 3 | <1% |
| Mobility | 2 | <1% |
| Support another treatment | 2 | <1% |
| Bulbar symptoms | 1 | <1% |
| Anxiety | 1 | <1% |
| Pain | 1 | <1% |
How long current patients have been taking Riluzole or how long patients were taking Riluzole before stopping.
Results from 45 patient evaluations. See the overall results and all individual evaluations.
| Moderate | 12% | 5 |
|---|---|---|
| Slight | 7% | 3 |
| None | 5% | 2 |
| Can't tell | 77% | 33 |
Slow my ALS progress
| Severe | 9% | 4 |
|---|---|---|
| Moderate | 11% | 5 |
| Mild | 9% | 4 |
| None | 71% | 32 |
Top reported side-effects include: Fatigue, Muscle weakness, Loose stools
Summary results are based on 45 individual responses. For more information, see overall results for Adherence, Burden and Cost.